Inhibitory activities of colicins against Escherichia coli strains responsible for postweaning diarrhea and edema disease in swine

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 8, 2004, Pages 3119-3121

  Stahl, Chad H ^a   Callaway, Todd R ^b   Lincoln, Leslie M ^a   Lonergan, Steven M ^a   Genovese, Kenneth J ^b  

^a IOWA STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; COLICIN E1; COLICIN N; MITOMYCIN C; PROTEIN;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DIARRHEA; DOSE TIME EFFECT RELATION; DRUG EFFICACY; EDEMA; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; IN VITRO STUDY; INFECTION PREVENTION; NONHUMAN; PIG FARMING; PREVALENCE; PRIORITY JOURNAL; STRAIN IDENTIFICATION; SWINE DISEASE; UNITED STATES;

COLICINS; DIARRHEA; EDEMA DISEASE OF SWINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; SWINE DISEASES;

EID: 3342920696     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.8.3119-3121.2004     Document Type: Article

References (13)

1. Cao, Z., and P. E. Klebba. 2002. Mechanism of colicin binding and transport through outer membrane porins. Biochimie 84:399-412.
2. Choi, C., H. J. Ham, D. Kwon, J. Kim, D. S. Cheon, K. Min, W. S. Cho, H. K. Chung, T. Jung, K. Jung, and C. Chae. 2002. Antimicrobial susceptibility of pathogenic Escherichia coli isolated from pigs in Korea. J. Vet. Med. Sci. 64:71-73.
3. Federal Register. 1999. Consideration of the human health impact of the microbial effects of antimicrobial new animal drugs intended for use in food producing animals. Food and Drug Administration guidance no. 78. Fed. Regist. 64:70715.
4. Federal Register. 2002. Evaluating the safety of antimicrobial new animal drugs with regard to their microbiological effects on bacteria of human health concern. Food and Drug Administration draft guidance no. 152. Fed. Regist. 67:58058.
5. Fredericti, P. 1957. Colicins. Annu. Rev. Microbiol. 11:7-22.
6. Jordi, B. J. A. M., K. Boutaga, C. M. E. van Heeswijk, F. van Knapen, and L. J. A. Lipman. 2001. Sensitivity of Shiga toxin-producing Escherichia coli (STEC) strains for colicins under different experimental conditions. FEMS Microbiol. Lett. 204:329-334.
7. Lakey, J. H., and S. L. Slatin. 2001. Pore-forming colicins and their relatives. Curr. Top. Microbiol. Immunol. 257:131-161.
8. Lanz, R., P. Kuhnert, and P. Boerlfn. 2003. Antimicrobial resistance and resistance gene determinants in clinical Escherichia coli from different animal species in Switzerland. Vet. Microbiol. 91:73-84.
9. Lowry, O. H., N. J. Rosehrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
10. Murinda, S. E., R. F. Roberts, and R. A. Wilson. 1996. Evaluation of colicins for inhibitory activity against diarrheagenic Escherichia coli strains, including serotype O157:H7. Appl. Environ. Microbiol. 62:3196-3202.
11. Schamberger, G. P., and F. Diez-Gonzalez. 2002. Selection of recently isolated colicinogenic Escherichia coli strains inhibitory to Escherichia coli O157:H7. J. Food Prot. 65:1381-1387.
12. U.S. Department of Agriculture. 2001. Reference of swine health and management in the United States, 2002. N338.0801. National Animal Health Monitoring System, Fort Collins, Colo.
13. World Health Organization. 2000. Global principles for the containment of antimicrobial resistance in animals intended for food. [Online.] http://www .who.int/emc-documents/zoonoses/docs/whocdscsraph20004.pdf.